Kim Julie So-Young
SEC insider (Form 3/4/5 filer). CIK 0001977732. President and CEO at TAKEDA PHARMACEUTICAL CO LTD (TAK). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in CAMBRIDGE, MA.
Companies Kim Julie So-Young has filed insider reports for
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Director, Officer, President and CEO
Kim Julie So-Young
CIK: 0001977732
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SaleDirect89.1K shares at avg. $17.10$1.5M - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect50.4K shares- - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect22.8K shares- - Apr 27, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect105.4K shares-
1-4 of 4 transactions